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  The effect of intravesical chemotherapy on superficial urinary bladder cancer was analysed．
Fifty－nine patients with low－staged， low－grade bladder cancer were treated with intravesical instil－
lation of three anticancer drugs （adriamycin， carbazilquinone and bleomycin）． Complete response
（CR） was observed in 15 eut of 42 patients and partial response （PR） in 9 patients． Overall， a better
response rate was observed with adriamycin and carbazjlquinone than with bleornycin．
  PapMary tumors responded well to these intravesical chemotherapies compared to the non－papil－
larytumors． lntravesical recurrence of tumQrs was evaluated in 68 patients who received intravesical
instillation of these three drugs after TUR of tumors． The actuarial recurrence rate of 68 patients
was 11， 22 and 340／． within 1， 2 and S years， respectively． These rates were significantly lower than
that of TUR therapy alone． No serious side effect was seen in these patients． From these results，
it is noted that intravesical chemotherapy is a useful approach for controlling superficial urinary bladder
cancer．
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膀胱鏡
 ’
生検  （組織型、悪性度の決定 ）
 ・翼鶯叢
2回／週で8回 （4週） を1クール e
膀胱鏡にて効果判定
Fig．1．治療注入療法のスケジュール
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計 18 9 15 42
（43pm 〈21％）（36％）
Table．2，腫瘍性状による抗腫瘍効果
効 果   NR
就職性状   無 効
P R・ C R・
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